Facet browsing currently unavailable
Page 2 of 2161 results
Sort by: relevance publication year
Tyrosine kinase inhibitors: the role of pharmacokinetics and pharmacogenetics JOURNAL ARTICLE published 2 November 2023 in Expert Opinion on Drug Metabolism & Toxicology |
Farnesoid x receptor in human metabolism and disease: the interplay between gene polymorphisms, clinical phenotypes and disease susceptibility JOURNAL ARTICLE published 3 April 2015 in Expert Opinion on Drug Metabolism & Toxicology |
Inhaled human insulin ((insulin human [rDNA origin]) Inhalation Powder) in diabetes mellitus JOURNAL ARTICLE published October 2006 in Expert Opinion on Drug Metabolism & Toxicology |
Pharmacokinetics and pharmacodynamics of incobotulinumtoxinA influencing the clinical efficacy in post-stroke spasticity JOURNAL ARTICLE published 2 April 2016 in Expert Opinion on Drug Metabolism & Toxicology |
High-throughput pKascreening and prediction amenable for ADME profiling JOURNAL ARTICLE published February 2006 in Expert Opinion on Drug Metabolism & Toxicology |
Using drug probes to monitor hepatic drug metabolism in critically ill patients: midazolam, a flawed but useful tool for clinical investigation of CYP3A activity? JOURNAL ARTICLE published June 2010 in Expert Opinion on Drug Metabolism & Toxicology |
Inflammation and pharmacokinetics: potential implications for HIV-infection JOURNAL ARTICLE published 3 June 2017 in Expert Opinion on Drug Metabolism & Toxicology Research funded by Colorado HIV Research Training Program (5 T32 AI 7447-23) |
Pharmacokinetics of antiretrovirals in mucosal tissue JOURNAL ARTICLE published 3 June 2015 in Expert Opinion on Drug Metabolism & Toxicology |
A review of clinically significant drug-drug interactions involving angiotensin II receptor antagonists and antiepileptic drugs JOURNAL ARTICLE published 2 June 2020 in Expert Opinion on Drug Metabolism & Toxicology |
Crystal structure of arylamineN-acetyltransferases: insights into the mechanisms of action and substrate selectivity JOURNAL ARTICLE published March 2013 in Expert Opinion on Drug Metabolism & Toxicology |
Pharmacodynamics, pharmacokinetics and clinical efficacy of apixaban in the treatment of thrombosis JOURNAL ARTICLE published 3 May 2016 in Expert Opinion on Drug Metabolism & Toxicology |
Pharmacokinetic considerations in the use of antivirals in neonates JOURNAL ARTICLE published 2 December 2015 in Expert Opinion on Drug Metabolism & Toxicology |
Acute, transitional and long-term cluster headache treatment: pharmacokinetic issues JOURNAL ARTICLE published 1 September 2016 in Expert Opinion on Drug Metabolism & Toxicology Research funded by Instituto de Salud Carlos III-Sara Borrell program (CD13/00348) |
The influence of long-term treatment with psychotropic drugs on cytochrome P450: the involvement of different mechanisms JOURNAL ARTICLE published August 2005 in Expert Opinion on Drug Metabolism & Toxicology |
Related articles JOURNAL ARTICLE published August 2012 in Expert Opinion on Drug Metabolism & Toxicology |
Novel strategies for the treatment of migraine attacks via the CGRP, serotonin, dopamine, PAC1, and NMDA receptors JOURNAL ARTICLE published November 2014 in Expert Opinion on Drug Metabolism & Toxicology |
Related articles JOURNAL ARTICLE published September 2012 in Expert Opinion on Drug Metabolism & Toxicology |
Related articles JOURNAL ARTICLE published 4 May 2015 in Expert Opinion on Drug Metabolism & Toxicology |
Two-dimensional gels for toxicological drug discovery applications JOURNAL ARTICLE published February 2006 in Expert Opinion on Drug Metabolism & Toxicology |
Pharmacokinetic and pharmacodynamic interaction of DWP16001, a sodium-glucose cotransporter-2 inhibitor, with phentermine in healthy subjects JOURNAL ARTICLE published 3 July 2023 in Expert Opinion on Drug Metabolism & Toxicology |